Home › Asset managers › Compare 2025-2026 › American Century vs Prudential/PGIM
American Century 2025-2026 · Prudential/PGIM 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 23,483 | 20,883 | 1,426 | 1,174 | 93.6% | 91.2% |
| Board proposals | 21,622 | 19,321 | 1,327 | 974 | 93.6% | 91.4% |
| E&S shareholder proposals | 173 | 134 | 4 | 35 | 97.1% | 87.4% |
| Other items | 1,688 | 1,428 | 95 | 165 | 93.8% | 89.2% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
2,301 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | Prudential/PGIM |
|---|---|---|---|---|---|---|
| 1ST SOURCE CORPORATION | April 23, 2026 | Approval of Amended 1982 Restricted Stock Award Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| 1ST SOURCE CORPORATION | April 23, 2026 | Approval of Amended Strategic Deployment Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Charles G. McClure, Jr. Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Jeffrey A. Graves Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Jim D. Kever Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: John J. Tracy Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Malissia R. Clinton Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Thomas W. Erickson Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Vasant Padmanabhan Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| 4D MOLECULAR THERAPEUTICS, INC. | June 17, 2026 | Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers (''say-on-pay vote''). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| 908 DEVICES INC | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| A. O. Smith Corporation | April 13, 2026 | Election of directors: Lois M. Martin Director Elections |
Board | For | FOR 22 funds |
WITHHOLD 1 fund |
| AAR CORP. | September 16, 2025 | Advisory proposal to approve our Fiscal Year 2025 executive compensation Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| ABACUS GLOBAL MANAGEMENT, INC. | June 3, 2026 | Approval, by an advisory vote, of the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ABEONA THERAPEUTICS INC. | June 12, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 4 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Nancy McKinstry Director Elections |
Board | For | FOR 7 funds |
AGAINST 19 funds |
| ACCENTURE PLC | January 28, 2026 | To approve the Amended and Restated Accenture plc 2010 Share Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 20 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares available for future grant and eliminate fungible share counting provisions with respect to new awards. Compensation |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval, by non-binding advisory vote, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 4 funds |
| ACME UNITED CORPORATION | April 27, 2026 | Approval, by non-binding advisory vote, of the compensation of the named executive officers of the Company as described in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| ACNB CORPORATION | May 5, 2026 | To elect four (4) Class 3 directors to serve for terms of three (3) years and until their successors are elected and qualified. Kimberly S. Chaney Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| ADAPTHEALTH CORP. | June 18, 2026 | Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| AEBI SCHMIDT HOLDING AG | May 21, 2026 | Election of Barend Fruithof as the Chair of the Board of Directors Corporate Governance |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| AERCAP HOLDINGS N.V. | April 15, 2026 | Approve Report of the Nomination and Compensation Committee Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| AEROVIRONMENT, INC. | September 25, 2025 | Management proposal to approve the amendment and restatement of the company's 2021 equity incentive plan Compensation |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| AERSALE CORPORATION | June 11, 2026 | Approval, on an advisory basis, of the Company's named executive officer compensation. Compensation |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| AES CORP | April 29, 2026 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 8 funds |
| AFFIRM HOLDINGS, INC. | December 15, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 3 funds |
| AGILYSYS, INC. | September 4, 2025 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers set forth in the attached Proxy Statement Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To vote, on an advisory basis, to approve the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| AIR LEASE CORPORATION | December 18, 2025 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of Air Lease Corporation in connection with the merger (the ''Compensation Proposal''). Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| AIRBNB INC | June 5, 2026 | To elect Nathan Blecharczyk, Alfred Lin and James Manyika as Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: Nathan Blecharczyk. Director Elections |
Board | For | WITHHOLD 18 funds |
FOR 1 fund |
| ALARM.COM HOLDINGS, INC. | June 3, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 3 funds |
| ALEXANDER & BALDWIN, INC. | March 9, 2026 | To consider and vote on a proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers that is based on or otherwise relates to the merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| ALIMENTATION COUCHE-TARD INC | September 3, 2025 | ELECTION OF DIRECTOR: MELANIE KAU Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 3 funds |
| ALLY FINANCIAL INC. | May 6, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| ALPHA & OMEGA SEMICONDUCTOR LTD | November 12, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as described in the Proxy Statement Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| ALPHATEC HOLDINGS, INC. | June 10, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| AMENTUM HOLDINGS, INC | February 6, 2026 | Advisory vote to approve the Company's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| AMERICA'S CAR-MART, INC. | September 25, 2025 | To approve an advisory resolution regarding the Company's compensation of its named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 2 funds |
| AMERICAN AIRLINES GROUP INC. | June 10, 2026 | A proposal to approve the Amended and Restated 2023 Incentive Award Plan Compensation |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| AMERICAN INTERNATIONAL GROUP, INC. | May 13, 2026 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 18 funds |
| AMERICAN STATES WATER COMPANY | May 19, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| AMERICAN STATES WATER COMPANY | May 19, 2026 | To approve the 2026 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| AMERICAN SUPERCONDUCTOR CORPORATION | July 25, 2025 | To approve, on an advisory basis, the compensation of AMSC's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| AMERICAN VANGUARD CORPORATION | July 2, 2025 | Resolved, that the compensation paid to the Company's named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby approved. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| AMERICAN WELL CORP (AMWELL) | June 16, 2026 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in executive compensation and the related compensation tables and narrative disclosure in the Company's proxy statement Say-on-Pay |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| AMERICAN WOODMARK CORPORATION | August 21, 2025 | To approve on an advisory basis the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| AMERICAN WOODMARK CORPORATION | October 30, 2025 | To approve, on an advisory (non-binding) basis, the compensation that will or may be paid to American Woodmark's named executive officers in connection with the transactions contemplated by the merger agreement; and Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| AMICUS THERAPEUTICS, INC. | March 3, 2026 | To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| AMPHASTAR PHARMACEUTICALS INC. | June 1, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 3 funds |
| AMPLITUDE, INC. | June 9, 2026 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| AMREP CORPORATION | September 11, 2025 | Approval, on an advisory basis, of the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| AMREP CORPORATION | September 11, 2025 | Election of one (1) director in Class II to hold office until the 2028 annual meeting of shareholders and until his successor is elected and qualified. Robert E. Robotti Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| ANGIODYNAMICS, INC. | November 10, 2025 | Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| ANHUI CONCH CEMENT CO LTD | May 28, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 3 funds |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 4 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Approval of the Amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| ANNEXON, INC. | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| AON PLC | June 26, 2026 | Advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 16 funds |
| APA CORPORATION | May 21, 2026 | Advisory vote to approve the compensation of APA's named executive officers Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 11 funds |
| APOGEE ENTERPRISES, INC. | June 24, 2026 | APPROVAL OF THE APOGEE ENTERPRISES, INC. 2019 STOCK INCENTIVE PLAN, AS AMENDED AND RESTATED (2026) TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR AWARDS FROM 2,150,000 TO 2,950,000. Compensation |
Board | For | AGAINST 10 funds |
FOR 2 funds |
| APOGEE THERAPEUTICS, INC. | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| APPFOLIO, INC. | June 12, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| AQUESTIVE THERAPEUTICS, INC. | June 10, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ARCBEST CORPORATION | April 24, 2026 | To approve the reincorporation of the Company to the State of Texas by conversion. Extraordinary Transactions |
Board | For | FOR 10 funds |
AGAINST 2 funds |
| ARCTURUS THERAPEUTICS, HOLDINGS INC. | June 5, 2026 | Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 8 funds |
| ARDELYX, INC | June 16, 2026 | To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. Compensation |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| ARDELYX, INC | June 16, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission (''Say-on-Pay''); Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| ARMOUR RESIDENTIAL REIT, INC. | April 30, 2026 | To approve ARMOUR's Fourth Amended and Restated 2009 Stock Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ARQ, INC. | June 10, 2026 | To approve the Arq, Inc. 2026 Omnibus Incentive Plan; and Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| ARRAY DIGITAL INFRASTRUCTURE, INC. | October 9, 2025 | Advisory vote to approve executive compensation Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 5 funds |
| AST SPACEMOBILE, INC. | June 12, 2026 | To approve the non-binding advisory resolution on the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| ASTRAZENECA PLC | April 9, 2026 | Re-elect Marcus Wallenberg as Director Director Elections |
Board | For | FOR 10 funds |
AGAINST 5 funds |
| ASTRIA THERAPEUTICS, INC. | January 21, 2026 | To cast a vote, on a non-binding, advisory basis, to approve the Merger-related named executive officer compensation as disclosed in the table entitled ''Golden Parachute Compensation'' and its accompanying footnotes which is included in the section of the proxy statement entitled ''The Merger-Interests of Astia's Directors and Executive Officers in the Merger,'' as required by Section 14A of the Securities Exchange Act of 1934, as amended, which was enacted as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| ATLAS COPCO AB | April 28, 2026 | REELECT HANS STRABERG AS BOARD CHAIR Corporate Governance |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| ATLAS COPCO AB | April 28, 2026 | REELECT HANS STRABERG AS DIRECTOR Director Elections |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| ATLAS COPCO AB | April 28, 2026 | REELECT PETER WALLENBERG JR AS DIRECTOR Director Elections |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| ATLAS ENERGY SOLUTIONS INC. | May 7, 2026 | Please indicate your vote, on a non-binding advisory basis, on the Company's Named Executive Officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| AUDIOEYE, INC. | June 22, 2026 | To approve, by non-binding advisory vote, the compensation of AudioEye, Inc.'s named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| AVADEL PHARMACEUTICALS PLC | January 12, 2026 | Ordinary resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| AVANOS MEDICAL,INC. | April 21, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 5 funds |
| AVANOS MEDICAL,INC. | April 21, 2026 | Approval of an amendment to the Company's 2021 Long Term Incentive Plan to allow for the issuance of awards thereunder to the Company's outside directors. Compensation |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| AVEPOINT, INC. | May 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 6 funds |
| AVIAT NETWORKS, INC. | November 5, 2025 | Advisory, non-binding vote to approve the Company's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| AVIAT NETWORKS, INC. | November 5, 2025 | Approval of Third Amended and Restated 2018 Incentive Plan of the Company. Compensation |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| AVIDITY BIOSCIENCES, INC. | February 26, 2026 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers in connection with the transactions contemplated by the Merger Agreement and the Separation Agreement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| AXA SA | April 30, 2026 | Reelect Gerald Harlin as Director Director Elections |
Board | For | AGAINST 4 funds |
FOR 6 funds |
| AXOGEN, INC. | June 23, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 2 funds |
Page 1 of 24 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.